HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Clif Kid Fills Zbars: Health And Wellness New Products

This article was originally published in The Rose Sheet

Executive Summary

Vital Protein goes vegan; Herbalife offers probiotic with GanedenBC30; Endexx rolls out CBD topicals; and more news in brief.

You may also be interested in...



Vital Proteins’ ‘Timely’ Immunity Product Launch Makes Time Right For Nestle Investment

Nestle Health Science has majority stake in US firm that started offering a powder blend for beverages containing vitamin C, collagen, L glutamine, zinc, electrolytes and beta glucan earlier in 2020, when consumer interest spiked in boosting immunity health.

Taro Agrees $36m Securities Settlement Over US Price-Fixing Claims

Sun’s Taro subsidiary is looking to move forward with an eight-figure settlement deal in the US, after plaintiffs including a firefighters’ pension fund accused the firm of misleading investors via its involvement in generic price fixing, leading to a fall in the price of its securities.

As Casgevy, Lyfgenia Launches Proceed, CRISPR And bluebird bio CEOs Reassure

The CEOs of bluebird bio and CRISPR Therapeutics hope to inspire investor confidence that their gene-based therapies for sickle cell disease and beta thalassemia will be widely reimbursed in the US and EU.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

RS121095

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel